Drug Profile
Granulocyte-macrophage colony-stimulating factor - BioTransplant
Alternative Names: GM-CSF - BioTransplant; Porcine GM-CSF; Porcine GM-CSF - BioTransplantLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator BioTransplant (CEASED)
- Class
- Mechanism of Action Granulocyte macrophage colony stimulating factor agonists; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Xenotransplant rejection
Most Recent Events
- 12 Mar 2004 It appears that BioTransplant has ceased operations
- 28 Nov 2003 BioTransplant expects to file with the Banruptcy Court in the coming weeks
- 28 Feb 2003 BioTransplant and Eligix have filed voluntary Chapter 11 petitions